# FDA Inspection 1192289 - Elyse S. Rafal, M.D. - November 17, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/elyse-s-rafal-md/3ececa26-6e42-4673-bc53-8a0d7cdaba81
Source feed: FDA_Inspections

> FDA Inspection 1192289 for Elyse S. Rafal, M.D. on November 17, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1192289
- Company Name: Elyse S. Rafal, M.D.
- Inspection Date: 2022-11-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1292742 - 2025-11-24](https://www.globalkeysolutions.net/records/fda_inspections/elyse-s-rafal-md/699fa502-bb8f-452f-9c73-24927d307fa3)
- [FDA Inspection 1292742 - 2025-11-24](https://www.globalkeysolutions.net/records/fda_inspections/elyse-s-rafal-md/32b228da-84c2-4431-bc95-2c6f65d16ef4)
- [FDA Inspection 1247249 - 2024-08-01](https://www.globalkeysolutions.net/records/fda_inspections/elyse-s-rafal-md/bddd9c37-f88c-4207-9bf4-af57e33d2db6)

Company: https://www.globalkeysolutions.net/companies/elyse-s-rafal-md/aa8514f3-88d5-4eaf-a609-5b928a2a542c

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c